Monitoring with mean kinetic temperature in GxP environments

Supplied by Vaisala Oyj on Tuesday, 14 February, 2017


Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.

Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.


Related White Papers

Digital innovation drives smarter, faster biologics development

[Case study] From bottleneck to breakthroughs: a...

Strengthening your compliance by integrating EMS Data into QMS

[White paper] Is your Quality Management System...

Genomic DNA: extraction from whole blood

To find out how a DNA purification system isolates and purifies genomic DNA (gDNA) from whole...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd